Top Pharmaceutical Research Companies in Spain
Compare top pharmaceutical research companies in Spain for 2026. Find verified HCP and patient panels to drive your brand strategy and market access success.
Quick answer
For large-scale data and commercial modeling, IQVIA and NIQ (GfK) are primary choices; for specialized, independent qualitative insights and hard-to-reach patient groups, Global Vox Populi and Pharmore Research are effective partners; for health economics and outcomes research in Spain, RTI Health Solutions is a specialist.
Securing reliable data in the Spanish healthcare sector requires working through a complex regulatory environment and specific local market dynamics. Brands must select partners capable of accessing verified clinicians and patients to generate actionable evidence that supports launch, market access, and brand positioning.
This assessment of pharmaceutical research companies in Spain provides a structured evaluation of providers to assist insights directors and brand managers in making informed decisions. By focusing on specialized capabilities, data quality, and panel integrity, this guide identifies the right agency for your specific research objective in 2026.
Top Pharmaceutical Research Companies in Spain: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Large-scale commercial data modeling | 88.0 |
| 2 | Global Vox Populi | Specialized patient and HCP research | 87.0 |
| 3 | RTI Health Solutions | Health economics and outcomes research | 86.0 |
| 4 | Ipsos Healthcare | Global healthcare trend tracking | 82.5 |
| 5 | Kantar | Brand equity and consumer behavior | 79.5 |
| 6 | GfK | Omnichannel market measurement | 75.5 |
| 7 | Q2Q Global | Boutique qualitative research | 74.0 |
| 8 | Pharmore Research | Independent pharmaceutical fieldwork | 71.0 |
| 9 | ESR Research | Specialized fieldwork and recruitment | 69.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Pharmacists, wholesalers, healthcare organizations | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | Physicians, patients, caregivers, payers, providers | License and registration checks, rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 46,104 healthcare professionals; 4,416 key opinion leaders; 1,139,370 patient profiles (in Spain; Global Vox Populi panel records, Oct 2026) | Not published |
| RTI Health Solutions | Payers, regulators, healthcare providers | Peer-reviewed methodology | Not stated on pages reviewed | Project quote | Not published | Not published |
| Ipsos Healthcare | Doctors, patients, citizens | Authenticated proprietary panels | Not stated on pages reviewed | Not published | Not published | Not published |
| Kantar | Consumers, healthcare purchasers | Qubed AI fraud detection | Not stated on pages reviewed | Not published | Not published | Not published |
| GfK | Retailers, consumers, policy makers | Transactional data validation | Not stated on pages reviewed | Not published | Not published | Not published |
| Q2Q Global | Healthcare professionals, patients, caregivers | In-house database and local recruiters | Not stated on pages reviewed | Project quote | Not published | Not published |
| Pharmore Research | KOLs, payers, patients | Highly qualified in-house interviewers | Not stated on pages reviewed | Project quote | Not published | Not published |
| ESR Research | Physicians, patients, general consumers | In-house telephone recruitment process | ESOMAR | Project quote | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | – | – | – | ● | – | ● |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| RTI Health Solutions | – | – | – | ● | – | ● |
| Ipsos Healthcare | ● | ● | ● | ● | – | ● |
| Kantar | ● | ● | ● | ● | – | ● |
| GfK | ● | – | – | ● | – | ● |
| Q2Q Global | ● | ● | ● | ● | – | ● |
| Pharmore Research | ● | ● | – | ● | – | ● |
| ESR Research | ● | ● | – | ● | – | ● |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their capability to deliver high-fidelity data and strategic clinical insights within the Spanish market.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the agency's depth of experience in the Spanish healthcare market. It covers knowledge of the local National Health System, therapeutic area nuance, and the ability to work through local regulations. High scores indicate an agency that understands the specific barriers to entry and prescriber behaviors in Spain. |
| Compliance, Certifications and Security | 20 | This assesses adherence to ISO standards, GDPR, and HIPAA, plus internal protocols for adverse event reporting. In Spain, this is fundamental for research involving physicians and patients. Providers must demonstrate rigorous data handling, secure storage, and ethical research practices to protect both the firm and the respondent. |
| Target Audience Reach | 15 | This evaluates the depth of access to specific Spanish audiences, including HCPs, KOLs, and patients. It considers panel size, profiling granularity, and the ability to recruit for low-incidence conditions. A strong score reflects an agency that does not rely on generic sample pools but owns its proprietary respondent databases. |
| Research Quality | 10 | This focuses on the rigor of study design, sampling methods, and data validation. It measures how effectively the agency detects fraud, bots, or straight-lining. For pharma research, data quality is the difference between a reliable strategic insight and a misleading conclusion that could impact product success. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This assesses the range of research methods offered, from online surveys and CATI to ethnographic studies and patient diaries. Agencies must be able to deploy the right tool for the objective, whether it involves complex conjoint analysis for pricing or qualitative interviews to map sensitive patient journeys. |
| Analytical Capability | 5 | This measures the ability to synthesize raw data into strategic business recommendations. It is not just about data collection, but about providing the insights needed for brand planning, competitive positioning, and launch strategy. Strong providers translate complex market findings into clear, actionable, and evidence-based reports for brand managers. |
| Client Service and Speed | 5 | This evaluates responsiveness, project management competence, and the ability to handle complications during fieldwork. In the fast-moving pharmaceutical sector, an agency must be proactive, transparent about timelines, and capable of adapting to unexpected shifts in the research plan without compromising the integrity of the project results. |
| Pricing and Feasibility Transparency | 5 | This measures the clarity of project proposals, including upfront disclosure of incidence rates and feasibility risks. Reliable agencies provide honest assessments of what is achievable, preventing budget waste on impossible recruitment targets. Transparency in project scope and costs builds the long-term trust required for successful pharmaceutical market research partnerships. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: pharmaceutical research companies in Spain
IQVIA: best for large-scale commercial data modeling

Strongest fitSuited for large pharmaceutical organizations needing integrated commercial data, predictive modeling, and strategic market analytics.
IQVIA is a global entity with a significant presence in Spain, focusing on the intersection of data, technology, and human science. They offer comprehensive insights that span the entire product lifecycle.
Their Spanish operations provide pharmaceutical companies with market dynamics analysis and HCP perception studies. They are known for using proprietary data assets to support strategic commercial decisions and site identification for clinical trials.
Scorecard: 88.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.0 |
Core services
- Market Intelligence: Tracks global pharma sales and provides dashboards for performance benchmarking and market opportunity assessment.
- Commercial Consulting: Offers strategic guidance on tactical challenges, including customer program design and patient adherence monitoring.
- Functional Outsourcing: Provides flexible FSP solutions to integrate expertise into clinical and commercial operations.
Strengths
- Data-Driven Insights: Uses petabytes of proprietary, non-identified patient records to provide extensive market visibility.
- End-to-End Solutions: Integrates clinical trial data with commercial market insights to maximize asset success.
Innovation and technology
- Agentic AI Platform: Uses AI-driven platforms like IQVIA.ai to optimize clinical operations and field force performance.
Impact on businesses
- Commercial Acceleration: Helps organizations speed up decision-making and reduce risk in competitive environments.
Why it may fit your brief
IQVIA is ideal for clients requiring massive data sets and commercial modeling. Smaller firms or those looking for agile, bespoke qualitative research may find more value in specialized boutique agencies.
Global Vox Populi: best for specialized patient and HCP research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitBest suited for brand managers and insights teams requiring high-quality, verified data from hard-to-reach patient and physician groups in Spain.
Global Vox Populi operates as an independent primary market research provider with a dedicated focus on healthcare. Its approach in Spain is centered on maintaining proprietary, verified panels that allow for precise targeting of niche therapeutic areas and complex respondent groups.
The agency provides end-to-end research support, from study design to data delivery. Its infrastructure is built for high-stakes pharmaceutical research, emphasizing data security, rigorous quality control, and strict adherence to adverse event reporting protocols as per industry standards.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Spain
46,104 panellists
- Primary & General16,856
- Internal Medicine Subspecialties5,170
- Surgical Specialties3,580
- Diagnostic & Laboratory3,388
- Acute, Peri-operative & Critical Care3,240
- Women's & Reproductive Health2,996
Key opinion leader panel, in Spain
4,416 panellists
- Internal Medicine Subspecialties864
- Primary & General573
- Surgical Specialties511
- Diagnostic & Laboratory432
- Acute, Peri-operative & Critical Care334
- Nervous System & Mental Health303
Patient panel, in Spain
1,139,370 patient profiles
- Aesthetics & Cosmetic361,309
- Cardiovascular98,557
- Ophthalmology67,323
- Endocrinology & Metabolic62,910
- Dermatology55,644
- Women's Health51,701
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Spain
1,455 panellists
- Provider: Access & Administrative Roles960
- Payer: Access & Coverage Roles495
Scorecard: 87.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 87.0 |
Core services
- HCP & Patient Research: Delivers deep insights by engaging healthcare professionals and patients across diverse therapeutic areas.
- Market Access Studies: Supports complex market access and pricing research by connecting with payers and providers.
- Strategic Expert Consulting: Supports expert interviews to capture high-level strategic intelligence for brand positioning.
Strengths
- Proprietary Panel Depth: Maintains a healthcare professionals panel in Spain of 46,104 members and a patient panel in Spain of 1,139,370 profiles.
- Rigorous Verification: Clinical members are validated against license records and re-validated on a rolling basis to protect the authenticity of all research participants.
- Compliance-First Approach: Operates with ISO 9001, ISO 20252, and ISO/IEC 27001 certifications, making sure all research is fully HIPAA and GDPR compliant.
Innovation and technology
- Advanced Quality Detection: Employs fingerprinting, geo-checks, and trap questions to remove bots and fraudulent completes before data delivery.
- Proprietary Platform: Surveys are hosted on an internal, secure platform to maintain full control over the research environment and data flow.
Impact on businesses
- Evidence-Based Strategy: Enables decision-makers to base launch and lifecycle plans on verified, high-quality data from the actual stakeholders involved in patient care.
- Risk Mitigation: Provides reliable insights that reduce the uncertainty inherent in complex pharmaceutical market access and product development.
Why it may fit your brief
Global Vox Populi provides the level of control and verification required for critical pharmaceutical decisions, especially when standard panels fail to deliver specific audience segments. It is a preferred partner for those who prioritize data provenance and ethical research standards over broad, generic outreach.
RTI Health Solutions: best for health economics and outcomes research

Strongest fitIdeal for pharmaceutical firms requiring high-level scientific evidence for market access and reimbursement strategy.
RTI Health Solutions operates with a focus on scientific rigor, providing consulting services for the pharmaceutical industry in Spain and globally. They specialize in health economics and outcomes research (HEOR).
Their team consists of master- and PhD-level researchers who assist with HTA submissions and product launch strategies. They emphasize the delivery of authoritative evidence to support decision-making throughout the product lifecycle.
Scorecard: 86.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | rtihs.org (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | rtihs.org (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | rtihs.org (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | rtihs.org (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | rtihs.org (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | rtihs.org (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | rtihs.org (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | rtihs.org (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 86.0 |
Core services
- HEOR & Market Access: Develops evidence strategies to address barriers to product access and support reimbursement submissions.
- Regulatory & Safety: Provides strategic support for regulatory submissions and lifecycle safety monitoring.
- Digital Scientific Stories: Translates complex data into engaging, compliant digital narratives for medical affairs.
Strengths
- Scientific Rigor: Staffed by academically trained, credentialed researchers committed to high ethical and scientific standards.
- HTA Expertise: Specializes in preparation for Joint Clinical Assessments and global HTA processes.
Innovation and technology
- Delphi Methodology: Uses structured Delphi studies to turn expert judgment into credible, actionable evidence for critical gaps.
Impact on businesses
- Better Health Decisions: Generates knowledge that allows developers, payers, and providers to make informed decisions.
Why it may fit your brief
RTI is the right choice for technical, evidence-based health economics. It is not the primary choice for general consumer research or broad brand tracking surveys.
Ipsos Healthcare: best for global healthcare trend tracking

Strongest fitFits global pharmaceutical brands needing consistent, cross-market insights into physician and patient sentiments.
Ipsos Healthcare provides specialized services in Spain for pharmaceutical clients, combining global methodologies with local market understanding. They focus on measuring perceptions of health systems and therapeutic areas.
Their work supports brand health tracking and patient journey exploration. They emphasize the need for reliable information to turn data into actionable truth for decision-makers.
Scorecard: 82.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.5 |
Core services
- HCP & Patient Research: Conducts specialized surveys and qualitative research with doctors and patients to understand healthcare decision-making.
- Brand Health Tracking: Monitors brand performance and market understanding through longitudinal research methodologies.
- Trend Analysis: Publishes global reports on health service perceptions and public health problems.
Strengths
- Global Reach: Delivers research across dozens of countries with authenticated, proprietary panelists.
- Specialized Expertise: Combines scientific rigor with technological know-how to deliver true understanding of society and markets.
Innovation and technology
- AI-Driven Insights: Integrates AI to deliver insights faster and more consistently across diverse healthcare markets.
Impact on businesses
- Confident Decision Making: Enables clients to make bolder, smarter decisions by providing accurate and relevant information.
Why it may fit your brief
Ipsos is well-positioned for large-scale, international healthcare studies. It is less suited for projects requiring extreme boutique focus or highly specialized, non-survey-based clinical evidence work.
Kantar: best for brand equity and consumer behavior

Strongest fitBest for consumer-facing healthcare brands looking to optimize brand equity and advertising effectiveness.
Kantar provides intelligence to help brands in Spain shape their future through deep human understanding. Their research spans consumer health and pharmaceutical brand strategy.
The agency uses large-scale data and proprietary frameworks to analyze brand equity and consumer decision processes. They emphasize the integration of survey data with third-party sources to provide a holistic view of the market.
Scorecard: 79.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.5 |
Core services
- Brand Valuation: Analyzes brand equity across thousands of categories and markets using extensive consumer data.
- Market Research Services: Offers custom survey design and fieldwork management to support product development and brand growth.
- Audience Activation: Identifies research segments to fuel scaled, addressable audiences for digital marketing.
Strengths
- Global Panel Reach: Operates proprietary premium panels and provides programmatic access to millions of respondents across 100 markets.
- Anti-Fraud Technology: Uses Qubed AI to identify fraudulent survey activity in real-time through deep neural networks.
Innovation and technology
- Agile Market Research: Kantar Marketplace combines agile research products with powerful analytics to accelerate consumer understanding.
Impact on businesses
- Strategic Growth: Turns human understanding into meaningful business outcomes to increase ROI and brand salience.
Why it may fit your brief
Kantar excels in consumer-centric research. Those needing highly technical clinical or payer-focused medical research may prefer agencies with dedicated healthcare-only specializations.
GfK: best for omnichannel market measurement

Strongest fitBest for companies requiring retail-level data and broad consumer trend analysis in the health and wellness space.
GfK, as part of NIQ, provides a wide view of consumer intelligence in Spain. They support the pharmaceutical and consumer health industries with rigorous market measurement.
Their approach connects trusted data with AI to help companies understand market trends and consumer choices. They are recognized for their ability to synthesize complex transactional data into actionable insights.
Scorecard: 75.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | gfk.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | gfk.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | gfk.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | gfk.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | gfk.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | gfk.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | gfk.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | gfk.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 75.5 |
Core services
- Market Measurement: Tracks consumer transactions and retail sales to provide a complete view of market dynamics.
- Consumer Behavior Insights: Uses AI-powered platforms to analyze how consumers choose and adapt their purchasing strategies.
- Media Analytics: Provides brand and media analytics to help retailers and manufacturers drive sustainable growth.
Strengths
- Data Scale: Covers billions in consumer spending through a comprehensive transactional database across 90 countries.
- AI Workflow Automation: Embeds AI across workflows to move from manual analysis to faster, smarter execution.
Innovation and technology
- Full View Platform: Connects trusted data, business context, and AI tools into a single intelligence layer.
Impact on businesses
- Growth Identification: Reveals new pathways to growth by providing clear understanding of omnichannel buying behavior.
Why it may fit your brief
GfK/NIQ is a leader in data-heavy retail measurement. It may be less effective for firms seeking deep, qualitative clinical insights into specific medical practice patterns.
Q2Q Global: best for boutique qualitative research

Strongest fitSuited for clients wanting a boutique, highly personal service for complex qualitative projects.
Q2Q Global operates as a specialist consultancy, focusing on uncovering the ‘why’ behind human behavior. They maintain active research networks in Spain to support global brands.
The agency prides itself on a personal approach, providing end-to-end management of research projects. They combine human expertise with technology to make sure that research is both culturally nuanced and logistically precise.
Scorecard: 74.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | q2qglobal.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | q2qglobal.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | q2qglobal.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | q2qglobal.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | q2qglobal.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | q2qglobal.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | q2qglobal.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | q2qglobal.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.0 |
Core services
- Qualitative Research: Specializes in in-depth interviews and telephone-depth interviewing to explore nuanced respondent experiences.
- Pharma Research: Provides insights into HCPs, patients, and caregivers to support product lifecycle management.
- Quantitative Execution: Conducts large-scale quantitative research, including CATI and in-home usage tests.
Strengths
- Cultural Nuance: Brings local expertise and cultural understanding to research execution across 60+ countries.
- Seasoned Team: Features a team of experts with an average of 16 years of experience in market research.
Innovation and technology
- Human-AI Integration: Combines AI power with human expertise to deliver smarter, more actionable insights.
Impact on businesses
- Meaningful Connections: Helps businesses build connections and stay relevant in changing markets through real-world insights.
Why it may fit your brief
Q2Q is excellent for customized qualitative work. Large firms with standardized, high-volume data needs may prefer a larger, more automated agency.
Pharmore Research: best for independent pharmaceutical fieldwork

Strongest fitIdeal for pharma companies looking for a specialized, independent fieldwork partner with deep local knowledge of the Spanish NHS.
Pharmore Research is an independent agency that has focused exclusively on the pharmaceutical and healthcare sectors for over 20 years. They are based in Spain and provide comprehensive fieldwork support.
Their approach is built on deep knowledge of the local Spanish NHS and a commitment to acting as a trusted advisor to their clients. They manage projects from problem definition through to final reporting.
Scorecard: 71.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | pharmoreresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | pharmoreresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | pharmoreresearch.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | pharmoreresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | pharmoreresearch.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | pharmoreresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | pharmoreresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | pharmoreresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 71.0 |
Core services
- Fieldwork Management: Provides end-to-end data collection, including recruitment and moderation for pharmaceutical studies.
- Strategic Consulting: Acts as an extension of the client's team to protect effective and ethical research outcomes.
- Multi-market Coordination: Manages complex multi-market studies across the top 5 European countries and beyond.
Strengths
- Healthcare Specialization: Exclusively focused on the healthcare sector for over 20 years, protecting deep industry knowledge.
- Proprietary Database: Maintains an in-house database and works with highly qualified interviewers across Spain.
Innovation and technology
- Complex Project Handling: Expertise in managing complex research, including rare disease studies and payer engagement.
Impact on businesses
- Long-term Success: Strives for long-term growth and success by providing responsive and productive research support.
Why it may fit your brief
Pharmore is a dedicated healthcare fieldwork specialist. It is less suited for general consumer projects or firms requiring massive, automated global data platforms.
ESR Research: best for specialized fieldwork and recruitment
Strongest fitBest for research agencies and pharma brands needing reliable, high-quality fieldwork and recruitment in Spain.
ESR Research, formerly Estudio Silvia Roca, brings decades of experience to fieldwork in Spain. They focus on providing a comprehensive service for both qualitative and quantitative projects.
The agency is known for its physical meeting facilities and its ability to manage complex recruitment processes. They follow strict quality control standards to protect the reliability of their fieldwork.
Scorecard: 69.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | esr-research.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 69.0 |
Core services
- Fieldwork Execution: Handles end-to-end recruitment and data collection for diverse research projects.
- Qualitative Facilitation: Provides physical and virtual meeting spaces for focus groups, IDIs, and advisory boards.
- Quantitative Data: Executes CATI, CAPI, and CAWI projects with stringent quality control.
Strengths
- Long-standing Experience: Over 30 years of experience in market research fieldwork and participant recruitment.
- Quality Standards: Complies with the standards of major research associations and recommendations from INTELLUS Worldwide.
Innovation and technology
- Modern Facilities: Offers specialized rooms with advanced technology for video screening and translation.
Impact on businesses
- Business Guidance: Assists clients in seeking competitive advantages and solving branding and image issues.
Why it may fit your brief
ESR is a strong fieldwork partner. It may not be the primary choice for firms seeking comprehensive strategic consulting or complex health economic modeling.
How HCP and patient verification actually works in Spain
Verify participant identity through license checks and validated registries to protect the integrity of your research sample.
Standardized Verification Procedures
In the Spanish pharmaceutical market, verification must go beyond self-identification. For physicians, agencies should cross-reference license numbers against official medical registries (Colegio de Médicos) to confirm active status and specialty. For patient groups, recruitment should occur through verified channels like patient advocacy organizations or medical centers. Always ask the agency for their specific protocol regarding identity validation, re-validation frequency, and how they handle discrepancies. A lack of transparent, documented verification processes is a major red flag that often leads to low-quality data or fraudulent professional responses.
How to choose the right provider in Spain
Select a partner based on the specific methodological requirements of your pharmaceutical project.
- Define project goals: Determine if you need broad quantitative market tracking or deep qualitative insights into patient behaviors. Each objective requires different agency strengths.
- Check healthcare focus: Prioritize agencies that demonstrate a consistent, exclusive focus on the pharmaceutical and healthcare sectors. Generalist firms often lack the necessary regulatory nuance.
- Assess panel ownership: Confirm whether the agency owns its panels or rents them from third parties. Proprietary, verified panels offer significantly higher data quality.
- Verify compliance rigor: Protect the agency follows strict data protection and adverse event reporting guidelines. Ask for evidence of their internal quality and security protocols.
- Review local expertise: Verify the agency’s knowledge of the Spanish healthcare system, including local market access dynamics and prescriber behaviors.
Questions to ask before you commission
- Can you provide proof of how your physician panels are validated against official Spanish medical registries?
- What specific procedures do you have in place for reporting adverse events during the research process?
- How do you make sure that patient respondents are genuinely diagnosed with the therapeutic condition being studied?
- Can you describe your methodology for detecting fraudulent responses or bots in your quantitative surveys?
- What experience do you have with Spanish market access and HTA-related research?
- Will you provide a transparent summary of your feasibility and expected incidence rates before we sign the project agreement?
Common pitfalls to avoid
- Relying on generic panels: Using broad, unverified consumer panels for medical research often leads to low-quality insights and professional misrepresentation.
- Ignoring local regulations: Failing to account for the specific compliance and data protection laws in Spain can result in significant legal and reputational risks.
- Underestimating recruitment difficulty: Assuming high-incidence rates for rare disease patients or niche specialists without checking feasibility can cause major project delays.
- Lack of adverse event training: Working with an agency that is not trained in adverse event reporting procedures puts the client at risk of regulatory non-compliance.
What a feasibility check should include
Require a detailed feasibility report that accounts for local market incidence and respondent availability.
Incidence rate analysis
Always ask for a realistic estimate of the incidence rate for your target population in Spain. An honest agency will warn you if your criteria are too restrictive.
Sample source validation
Confirm the source of your sample. If the agency is not using their own panels, ask how they vet the third-party providers they are using.
Timeline transparency
Request a clear timeline that includes recruitment, data collection, and quality control phases. Avoid agencies that promise unrealistic turnaround times.
Participant availability
Check if your target HCPs or patients are accessible during the proposed research window, considering local holidays and professional schedules.
Conclusion
Selecting the right partner among the pharmaceutical research companies in Spain depends on the nature of your project. For large-scale data modeling and commercial analytics, established firms like IQVIA and GfK offer the scale required for broad market visibility. If your objective is high-fidelity qualitative insight, patient journey mapping, or targeted physician recruitment, independent specialists such as Global Vox Populi and Pharmore Research provide the necessary control and panel integrity.
Use the scorecard provided in this assessment to match your specific needs, whether it is technical HEOR support from RTI Health Solutions or broad brand equity tracking from Kantar, against the proven capabilities of each provider. Make sure that compliance, data verification, and feasibility transparency remain at the center of your selection process to safeguard your strategic investments in the Spanish market.
Planning research in Spain? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
Which are the top pharmaceutical market research companies in Spain?
The market includes global intelligence leaders like IQVIA and GfK, specialized healthcare agencies such as Ipsos Healthcare and Pharmore Research, and independent specialists like Global Vox Populi and RTI Health Solutions. The choice depends on whether you require broad market data, niche qualitative insights, or technical health economics support.
How do I find a pharmaceutical market research agency in Spain?
Start by identifying your core research objective, such as launch tracking, patient journey mapping, or market access. Look for agencies with a proven, exclusive focus on healthcare, proprietary verified panels, and demonstrated knowledge of the Spanish healthcare system. Request evidence of their quality control and compliance standards early in the selection process.
Do global pharma research firms have offices in Spain?
Yes, many large global firms, including IQVIA, Kantar, Ipsos, and GfK, maintain established offices and dedicated teams in Spain. These firms often combine global research methodologies and infrastructure with local experts who understand the nuances of the Spanish market, providing a bridge between international standards and local requirements.
What services do pharmaceutical research companies in Spain provide?
Services typically include quantitative market tracking, qualitative patient and HCP interviews, brand equity research, health economics and outcomes research (HEOR), and market access strategy. Agencies also assist with site identification for clinical trials, prescription analytics, and the translation of complex clinical data into strategic reports for brand managers.
Are there specialized healthcare market research firms in Barcelona or Madrid?
Yes, there is a strong concentration of specialized healthcare research agencies based in both Barcelona and Madrid. These cities serve as the hubs for many firms, such as Pharmore Research and RTI Health Solutions, which maintain local offices to stay close to the pharmaceutical industry and the Spanish medical community.
How is pharmaceutical market research regulated in Spain?
Pharmaceutical research in Spain is governed by strict national and European data protection laws (GDPR) and industry-specific guidelines. Agencies must adhere to ethical codes, protect patient and professional anonymity, and maintain rigorous procedures for reporting adverse events or product complaints to the client, protecting the integrity and safety of the data.
What is the role of market research in Spanish pharmaceutical market access?
Market research is essential for gathering the evidence needed for reimbursement submissions and pricing strategy. It involves understanding the perspectives of payers, providers, and patients to demonstrate the value of a treatment. Research helps companies anticipate HTA requirements and align their evidence package with the expectations of the Spanish National Health System.
What is the importance of proprietary panels in this market?
Proprietary panels allow agencies to verify the identity and professional credentials of respondents, which is critical for medical research. Unlike rented sample pools, proprietary panels offer higher data quality, better targeting for low-incidence conditions, and more consistent access to niche healthcare professionals, reducing the risk of fraudulent or inaccurate data.